Varian Explores Strategic Partnership with Ping An Health To Expand China Cancer Care

Varian, a medical technology company based in Palo Alto, California, is exploring a strategic partnership with China-based Ping An Health Technology Co., Ltd., with a focus on expanding access to cancer care in China.

Leveraging their respective technical and domain expertise, the two companies will investigate the utilization of artificial intelligence, cloud computing and big data technologies, to deliver high quality and cost-effective cancer care to a far greater number of people in China, and close to where they live.

Varian and Ping An share a common vision of improving the digitalization and understanding of the entire cancer life cycle, covering prevention, detection, diagnosis, treatment, rehabilitation and palliation. Through their combined efforts, Varian and Ping An will look to create a more comprehensive tool to help healthcare professionals increase the effectiveness of treatment methods such as surgery, chemotherapy, molecular medicine and radiation therapy.

"We are pleased to be collaborating with Ping An, the leading force in the field of healthcare in China, on ways to expand the access to high-quality and cost-effective cancer care in China," said Kevin O'Reilly, president of Asia Pacific for Varian. "By leveraging Varian's advanced technologies and solutions in care management and treatment and Ping An's infrastructure and market reach, together we have the potential to enable a higher level of care for cancer patients in China."

"The cooperation with Varian is a significant milestone for Ping An Health Technology, which expands the development of Ping An Medical and Health in the field of radiation oncology technology," said Mao Biao, director of the Strategic Development Center of Ping An Group. "We look forward to this partnership and how the two companies can collaborate in the fight against cancer."